Form 10-Q CATALYST PHARMACEUTICAL For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Catyalyst Pharma (CPRX) Tops Q1 EPS by 2c
May 11, 2015 4:31 PM EDTCatyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
... More